Another strong performance for AstraZeneca who continue to thrive in the pharma innovation and invention space, ranking 7th on the Innovation Index and 3rd on the Invention Index. They achieved significant regulatory milestones, including three first NME approvals, 17 NMEs in late-stage development, and 123 NME or major LCM projects in Phase 2 or 3. Key approvals include among others: Airsupra (albuterol/budesonide), an as-needed treatment to reduce risk of asthma exacerbations; Truqap (capivasertib), a first-in-class AKT inhibitor for certain breast cancer indications with one or more biomarker alterations; and Wainua (eplontersen), the only approved self-administered auto-injector for the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. See the full analysis at - www.ideapharma.com/pii #pharmaceutical #innovation #PIII2024
IDEA Pharma | From R&D to RxD’s Post
More Relevant Posts
-
Unlock your potential with SmartLabs’ fully customizable laboratory environments and comprehensive support services. Access world-class research spaces tailored to your unique needs, with expert support at every stage of your R&D journey. Discover more about our innovative solutions today: https://hubs.ly/Q02S2Q8v0 #Biotech #Pharma #Innovation #SmartLabs #Infrastructure #Investments #Technology #ClinicalTrials #Biotech #LifeScience #Pharma #Pharmaceutical #DrugDevelopment #DrugManufacturing #ClinicalData #BusinessDevelopment #CellTherapy #GeneTherapy #MarketResearch #Biopharma #DrugDiscovery #oncology #Immunology #VentureCapital #StartUp
To view or add a comment, sign in
-
In today's competitive BioPharma landscape, achieving sustainable success requires more than just traditional strategies. At Anervea, we leverage our proprietary AI-tech to help BioPharma companies streamline and optimize their Medical & Commercial objectives. We empower our clients to adapt to ever-evolving market dynamics and improve long-term performance. Discover how Anervea.AI can drive lasting success and resilience in your strategy. 🌐 Book a Demo: https://lnkd.in/duJ6iNsV #AI #BioPharma #RareDiseases #OrphanDiseases #Oncology #Commercialization #NewProductPlanning #MarketAccess #ProductLaunch #Anervea #CompetitiveIntelligence #CommercialOperations #BioPharmaMarketing #BusinessIntelligence #LifeScience #Biotech #Pharmaceutical
To view or add a comment, sign in
-
🚀 Maximize Your ADC Bioconjugation Processes with Cutting-Edge PAT Implementation 🧬 In the rapidly evolving landscape of biopharmaceuticals, Antibody-Drug Conjugates (ADCs) stand out as a beacon of innovation for targeted therapies. The fusion of precise targeting antibodies with potent cytotoxic drugs has revolutionized cancer treatment, but the complexity of their production cannot be understated. 🔍 Are you looking to stay ahead of the curve in ADC bioconjugation techniques? Merck Group invites you to dive into the world of Process Analytical Technology (PAT) through our on-demand webinar. Discover how PAT can be a game-changer in streamlining your bioconjugation processes, ensuring consistency, quality, and efficiency. ✅ Join us and unlock insights on: * The latest advancements in PAT for ADC manufacturing * Strategies to overcome common challenges in bioconjugation * Real-world applications and success stories 🔗 https://lnkd.in/eGMXygAX This comprehensive webinar is crafted for scientists, engineers, and industry professionals who are passionate about enhancing the therapeutic index of ADCs and optimizing their production workflow. Don’t miss this opportunity to empower your ADC bioconjugation processes with leading-edge technology. 📅 Available On Demand | Watch at Your Convenience #ADC #Bioconjugation #PAT #Webinar #Biopharmaceuticals #MerckKGaA #LifeScience #Innovation #DrugDevelopment #PharmaIndustry
Merck
sigmaaldrich.com
To view or add a comment, sign in
-
Skyhawk Therapeutics Has Advanced to the Multiple Ascending Dose Portion of its Phase 1 Study evaluating SKY-0515, a RNA-Targeting Small Molecule for Huntington's Disease. So what's next? They expect to begin enrolling Huntington's patients, who presently have few therapeutic options and none that reverse or slow disease progression. SKY-0515 has demonstrated strong activity in preclinical models which is believed will translate to patient benefit. What do you think of this news? #lifesciences #menloparklifesciences #pharmaceutical #pharma #science #skyhawk #SKY-0515
To view or add a comment, sign in
-
As the USAIC community gears up for our 18th BioPharma & Healthcare Summit in Boston on April 25th, we're taking a moment to reflect on the highlights from last year's summit. In case you missed it, we invite you to revisit this engaging fireside chat featuring industry titans Albert Bourla, Chairman & CEO of Pfizer, and Stelios Papadopoulos, Chairman of Exelixis and former Chairman of Biogen: https://lnkd.in/epmVU6xg Join us April 25 at The Newbury Boston Hotel for #USAIC24. This strategic summit is restricted to senior-level BioPharma industry executives, leading academicians, and investors. Limited seats. Please register to secure your spot: https://lnkd.in/gZsMybwx #innovation #leadership #biopharma #india #biotech #covid19 #research #healthcare #diversity #medicine #clinicaltrials #vaccines #pharmaceutical #fda #nih #pharma #oncology #raredisease #datascience #venturecapital
To view or add a comment, sign in
-
LAST FEW SPOTS AVAILABLE AND 5 DAYS TO GO! Join us & others at our Advanced Therapies Roundtable Xchange happening in #SanDiego, February 29th 2024. To view all facilitators, agendas, registration info and more, please visit: https://lnkd.in/eQAUQU7Y Note: Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #drugdiscovery #biotech #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #clinicaldevelopment #clinicalstudies #clinicaltrials #biomarkers #oncology #genomics #pharmaceutical #advancedtherapies #manufacturing #therapeutics #therapies #oligonucleotide #genetherapies
To view or add a comment, sign in
-
CQDM. We share. News from our ''Network'' Member TATUM bioscience in the newspaper LesAffaires: ''Beat cancer with the start-up Tatum Bioscience'' Successfully marketing a drug is an obstacle course that few start-ups manage to complete. But Tatum Bioscience from Sherbrooke intends to defy the predictions. Founded in 2019, this company focuses on an innovative approach to defeating cancer. “Our medicine is secreted by a bacteria, before being purified,” explains the president and co-founder, Jean-François Millau. This is completely different from a chemical-based medication. » Read: https://lnkd.in/eE4TzVrU Learn more about Tatum Bioscience and our other ''Network Members'' here: https://lnkd.in/euvbMRHY #lifesciences #biotechnology #drugdevelopment #innovation #funding #projects #medical #research #artificialintelligence #artificialintelligence #pharmaceutical #pharmaceutical #biopharma #biopharmaceutical #rna #rnatherapeutics #arn #facilitateinnovationbiopharma #membership #members #advantages Emmanuel Martinez
To view or add a comment, sign in
-
LAST FEW SPOTS AVAILABLE AND 5 DAYS TO GO! Join us & others at our Advanced Therapies Roundtable Xchange happening in #SanDiego, February 29th 2024. To view all facilitators, agendas, registration info and more, please visit: https://lnkd.in/exrsm4AC Note: Registration is only open to Senior Scientists and above actively working in the pharmaceutical/biotech industry. Each roundtable is limited to 8 participants. #hubXchangeNotAConference #pharma #drugdiscovery #biotech #bigdata #datasciences #lifesciences #drugdevelopment #pharmacology #clinicaldevelopment #clinicalstudies #clinicaltrials #biomarkers #oncology #genomics #pharmaceutical #advancedtherapies #manufacturing #therapeutics #therapies #oligonucleotide #genetherapies
To view or add a comment, sign in
-
Three days left before the Medical Alley Webinar! Join us for an engaging session featuring topics on clinical trials, such as common data management pitfalls, best practices for effective data collection, criteria for selecting the right technology, and more from expert insights from Medrio’s CEO Nicole DuPont Latimer and Amy Longcore. #SafeLanding Learn more and register here: https://lnkd.in/gPDNmspV #Webinar #ProfessionalDevelopment #IndustryInsights #Networking #Learning #Biotechnology #BioPharmaceutical #ClinicalDevelopment #ClinicalTrials #ClinicalOperations #Pharmaceutical #ClinicalResearch #Protocol #DrugDevelopment #ClinicalMonitoring #ClinicalDataManagement #RegulatoryAffairs #Oncology #Diabetes #Cardiovascular #ClinicalTrialEfficiency
To view or add a comment, sign in
-
Thrilling update! 🚀 Our newest brochure is out, featuring our specialized offerings for Biopharmaceutical Research and Development. 👉 With a focus on speeding up preclinical research and drug discovery, we're all about driving innovation. Interested in learning more? Reach out to us! #antibodies #antibody #assaydevelopment #diagnostic #durgdiscovery #immunoassay #ELISA #Biopharma #ResearchAndDevelopment #Innovation #Healthcare
To view or add a comment, sign in
18,468 followers